Table 2.

ICU characteristics and fungal screening.

Clinical data	A. fumigatus Group N = 35	Control Group N = 30	P value
Median ICU stay (in days) [range]	21 [3–44]	25 [3–70]	0.17
Median Apache II Score [range]	19 [8–38]	22 [13–33]	0.14
qSOFA Score ≥ 2	15/27 (43%)	13 (48%)	0.68
Survival at D90	21 (60%)	19 (63%)	0.78
Frequency of voriconazole treatment	14 (40%)	1 (3%)	< 0.001
Median number of tracheal aspirates analyzed during the ICU stay per patient [range]	5 [0–11]	4 [1–17]	0.83
Median number of broncho-alveolar lavage (BAL) analyzed during the ICU stay per patient [range]	1 [0–4]	0 [0–5]	0.45
Median number of antigen galactomanan measurements in serum [range]	2 [0–7]	3 [1–10]	0.04
Number of A. fumigatus qPCR on serum [range]	2 [0–7]	3 [1–10]	0.04